(1 - 16 from 21
)
A New Paradigm for Patient Recruitment TrialSiteNews
www.trialsitenews.com
17 Feb — ... potential patients and offer them a safer alternative to access innovative treatments,” said Mario Papillon, CEO at Cerba Research. › a-new-paradigm-for-pa...
BUSINESS WIRE: Cerba Research und ACT Genomics geben ...
moneyspecial.de
25 Aug — Mario Papillon, CEO von Cerba Research, kommentiert: "Dieser Meilenstein mit ACT Genomics ist eine Bestätigung unserer innovativen ... › news_news
Cerba HealthCare to Acquire Viroclinics-DDL
www.pharmoutsourcing.com
16 Dec — Cerba Research CEO Mario Papillon said: “The acquisition of Viroclinics-DDL is a milestone for Cerba Research, as it enables us to build a ... › News ›
Cerba Research, ACT Genomics to Open Joint Lab Facility in ...
www.precisiononcologynews.com
24 Aug — ... as a company," Mario Papillon, CEO of Cerba Research, a clinical trial service provider owned by Cerba HealthCare, said in a statement. › cerba-research...
sorted by relevance / date